Abolis joins EuropaBio: Sustainable Bio-Based Products

Brussels, 15 March 2021 – EuropaBio is pleased to announce that Abolis has joined as a Corporate member.

Abolis, from its head office near Paris, is at the forefront of the European development and manufacture of bio-based products for clients worldwide. It offers a combination of advanced genetic technologies, microbial biodiversity and bioinformatics capabilities to produce, via fermentation, a wide portfolio of complex molecules for food & feed, cosmetics, flavours & fragrances, specialty chemicals and pharmaceuticals.

It serves the rapidly expanding demand for bio-based products to replace conventionally produced chemicals and ingredients. Working closely with clients and partners, Abolis helps to establish technical and economic feasibility of a switch to bio-based, optimises the inner workings of micro-organisms’ metabolism and integrates downstream aspects of industrialisation from the first stages of development, as well as to enable novel branches of (bio)chemistry towards novel molecules and functionalities.

EuropaBio Director-General Dr. Claire Skentelbery commented “Abolis shows us the pathway forwards for European innovation from industrial biotechnology across all sectors. The company is a valuable addition to the EuropaBio community, as a rapidly expanding SME with global reach.”

Abolis CEO Cyrille Pauthenier added “As a fast-growing biotech company in the past years we have invested extensively into internal and proprietary technologies and know-how, established deep industrial relations and satisfied our first clients by reaching significant milestones. We are now more than happy to join EuropaBio, as part of our strategy to become the European leader in the field, by extending our network of industrial partnerships and product development pipeline to a broader pan-European audience.”

Download the full PRESS RELEASE below.